Creo Medical Group PLC (LSE:CREO) — Stock Price
Creo Medical Group PLC (LSE:CREO) is currently trading at GBX12.63 GBX, down 0.98% today. Over the past 52 weeks, shares have ranged between GBX9.90 and GBX17.75. This page tracks Creo Medical Group PLC's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Creo Medical Group PLC market cap and net worth.
Creo Medical Group PLC (CREO) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Creo Medical Group PLC's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Creo Medical Group PLC Income Statement — Revenue, Profit & Earnings by Year
Creo Medical Group PLC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | GBX6.00 Million | GBX4.00 Million | GBX30.80 Million | GBX27.17 Million | GBX25.16 Million |
| Cost of Revenue | GBX4.60 Million | GBX2.10 Million | GBX15.50 Million | GBX17.16 Million | GBX16.14 Million |
| Gross Profit | GBX1.40 Million | GBX1.90 Million | GBX15.30 Million | GBX10.01 Million | GBX9.02 Million |
| Research & Development | GBX7.50 Million | GBX11.10 Million | GBX11.80 Million | GBX13.53 Million | GBX12.87 Million |
| SG&A | GBX23.10 Million | GBX30.30 Million | GBX40.50 Million | GBX43.93 Million | GBX41.54 Million |
| Total Operating Expenses | GBX22.10 Million | GBX30.70 Million | GBX40.10 Million | GBX40.82 Million | GBX38.98 Million |
| Operating Income | GBX-20.70 Million | GBX-28.80 Million | GBX-24.80 Million | GBX-30.81 Million | GBX-29.96 Million |
| EBITDA | GBX-19.70 Million | GBX-26.10 Million | GBX-20.70 Million | GBX-27.62 Million | GBX-27.54 Million |
| EBIT | GBX-20.70 Million | GBX-28.60 Million | GBX-24.10 Million | GBX-30.73 Million | GBX-30.10 Million |
| Interest Expense | GBX300.00K | GBX400.00K | GBX400.00K | GBX248.00K | GBX363.00K |
| Income Before Tax | GBX-17.50 Million | GBX-29.00 Million | GBX-24.50 Million | GBX-30.98 Million | GBX-30.34 Million |
| Income Tax Expense | — | GBX-1.20 Million | GBX-2.80 Million | GBX-4.04 Million | GBX-5.74 Million |
| Net Income | GBX5.30 Million | GBX-28.70 Million | GBX-21.70 Million | GBX-26.94 Million | GBX-24.59 Million |
Creo Medical Group PLC Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Creo Medical Group PLC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | GBX59.10 Million | GBX65.00 Million | GBX76.60 Million | GBX75.34 Million | GBX100.61 Million |
| Total Current Assets | GBX23.50 Million | GBX56.40 Million | GBX37.90 Million | GBX33.69 Million | GBX61.17 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | GBX15.50 Million | GBX-153.00K | — |
| Net Receivables | GBX6.90 Million | GBX1.30 Million | GBX7.90 Million | GBX5.00 Million | GBX4.46 Million |
| Inventory | GBX2.50 Million | GBX2.70 Million | GBX8.10 Million | GBX9.32 Million | GBX8.50 Million |
| Property, Plant & Equipment | — | — | — | — | GBX8.60 Million |
| Goodwill | GBX0.00 | GBX0.00 | GBX19.10 Million | GBX19.56 Million | GBX18.56 Million |
| Total Liabilities | GBX9.10 Million | GBX22.60 Million | GBX16.80 Million | GBX25.93 Million | GBX27.29 Million |
| Total Current Liabilities | GBX7.30 Million | GBX20.50 Million | GBX9.90 Million | GBX17.48 Million | GBX19.74 Million |
| Long-term Debt | GBX1.80 Million | GBX1.90 Million | GBX4.40 Million | GBX4.89 Million | GBX3.79 Million |
| Net Debt | GBX-8.30 Million | GBX-4.30 Million | GBX5.30 Million | GBX-3.00 Million | GBX-32.98 Million |
| Total Stockholder Equity | GBX50.00 Million | GBX42.40 Million | GBX59.80 Million | GBX49.40 Million | GBX73.32 Million |
| Retained Earnings | GBX-153.80 Million | GBX-173.10 Million | GBX-144.40 Million | GBX-109.09 Million | GBX-82.16 Million |
Creo Medical Group PLC Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Creo Medical Group PLC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX-18.60 Million | GBX-22.20 Million | GBX-21.60 Million | GBX-24.99 Million | GBX-25.98 Million |
| Capital Expenditures | GBX900.00K | GBX400.00K | GBX1.20 Million | GBX3.27 Million | GBX6.12 Million |
| Free Cash Flow | GBX-20.00 Million | GBX-22.60 Million | GBX-22.80 Million | GBX-28.26 Million | GBX-32.10 Million |
| Investing Cash Flow | GBX19.40 Million | GBX15.30 Million | GBX-18.30 Million | GBX-6.03 Million | GBX-7.87 Million |
| Financing Cash Flow | GBX-700.00K | GBX16.20 Million | GBX29.80 Million | GBX400.00K | GBX31.99 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | GBX1.40 Million | GBX1.50 Million | GBX1.20 Million | GBX1.40 Million | GBX2.56 Million |
| Depreciation | GBX1.00 Million | GBX2.50 Million | GBX3.40 Million | GBX3.11 Million | GBX2.56 Million |
| Change in Cash | GBX3.70 Million | GBX9.30 Million | GBX-10.10 Million | GBX-30.44 Million | GBX-1.56 Million |
Creo Medical Group PLC Earnings History — EPS Actual vs. Analyst Estimates
Track Creo Medical Group PLC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 18, 2026 | — | — | — |
| Oct 06, 2025 | 0.00 | 0.00 | — |
| Sep 29, 2025 | 0.00 | — | — |
| May 19, 2025 | 0.00 | 0.00 | — |
| Sep 30, 2024 | -0.03 | 0.00 | — |
| Apr 26, 2023 | -0.07 | — | — |
| Sep 09, 2022 | -0.07 | — | — |
| Jun 02, 2022 | -0.09 | — | — |